Pharmacological inhibition of miR‐19a/b increases bone mass under physiological conditions, enhances the gain in bone mass by PTH therapy, and reverts bone loss in gonadectomy‐induced mouse models of osteoporosis. Here, PTH is linked to osteoporosis.